| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/01/2007 | WO2006119888A3 Butyrylcholinesterase as target/marker for insulin resistance |
| 02/01/2007 | WO2006116736A3 A method for the preparation of imaging probes using click chemistry |
| 02/01/2007 | WO2006116002A3 Tgf beta 1 specific antibodies |
| 02/01/2007 | WO2006106492A3 Assays for determining compounds which modulate tram phosphorylation |
| 02/01/2007 | WO2006101925A3 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| 02/01/2007 | WO2006096255A3 Thermoplastic film having metallic nanoparticle coating |
| 02/01/2007 | WO2006094198A3 Surfaces coated with target-induced fluorescent compounds for detection of target elements |
| 02/01/2007 | WO2006093651A3 Methods and kit for diagnosing tick borne illnesses |
| 02/01/2007 | WO2006091326A8 Anti-prl-3 antibodies and methods of use thereof |
| 02/01/2007 | WO2006083346A3 Device and method for passively measuring fluid and target chemical mass fluxes |
| 02/01/2007 | WO2006081158A3 Predictive and therapeutic markers in overian cancer |
| 02/01/2007 | WO2006076507A3 Self-activated sensor |
| 02/01/2007 | WO2006073429A3 Entrapped binding protein as biosensors |
| 02/01/2007 | WO2006073424A3 New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates |
| 02/01/2007 | WO2006042237A3 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 02/01/2007 | WO2006042004A3 Sample receiving device and methods of use thereof |
| 02/01/2007 | WO2006023382A3 Collagen vi and cancer |
| 02/01/2007 | WO2006007411A3 Methods and compositions for modulating bax-mediated apoptosis |
| 02/01/2007 | WO2006001813A3 Macrophage migration inhibitory factor as a marker for cardiovascular risk |
| 02/01/2007 | WO2005121778B1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 02/01/2007 | WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules |
| 02/01/2007 | WO2005089442A8 Inhibitors of gob-4 protein as asthma therapeutics |
| 02/01/2007 | WO2005077082A3 INHIBITING CAV3 ISOFORMS AND THE δ25B SPLICE VARIENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 02/01/2007 | WO2005072263A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
| 02/01/2007 | WO2005063745A9 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2005060461A3 Set-oriented real-time data processing based on transaction boundaries |
| 02/01/2007 | WO2005057167A3 Retaining clip for reagent test slides |
| 02/01/2007 | WO2004078923A3 Pyk2 crystal structure and uses |
| 02/01/2007 | WO2004024869A3 Cancer associated antigens, sga-56m and sga-56mv, and uses thereof |
| 02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
| 02/01/2007 | WO2003105773A3 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 02/01/2007 | WO2003065978A3 Crystals and structures of a flavin mononucleotide binding protein (fmnbp) |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070028311 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 02/01/2007 | US20070028310 Apparatus for selectively destroying dividing cells |
| 02/01/2007 | US20070027648 Clinical testing information processing apparatus, clinical testing information processing method, and analyzing system |
| 02/01/2007 | US20070027635 External quality control method, external quality control computer, preprocessing device, and nucleic acid detecting device |
| 02/01/2007 | US20070027634 Molecular hepatotoxicology modeling |
| 02/01/2007 | US20070027633 Method and system for designing proteins and protein backbone configurations |
| 02/01/2007 | US20070027632 Automated generation of multi-dimensional structure activity and structure property relationships |
| 02/01/2007 | US20070027631 Apparatus and method for evaluating a hypertonic condition |
| 02/01/2007 | US20070027565 Method and apparatus for order control in a production process for a fiber product |
| 02/01/2007 | US20070027383 Patches, systems, and methods for non-invasive glucose measurement |
| 02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027291 Structure and method for producing structure, toner containing structure, image forming method and device using toner |
| 02/01/2007 | US20070027215 Nuclear receptor ligands and ligand binding domains |
| 02/01/2007 | US20070027164 Agents for treating neurodegenerative diseases |
| 02/01/2007 | US20070027129 Taxane, magnetic moiety and covalent binder for production of magnetic antimitotic agent with higher toxicity to cancer cells than normal cells |
| 02/01/2007 | US20070027089 Inhibitors of amyloid precursor protein processing |
| 02/01/2007 | US20070026645 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors, and fabricating such devices |
| 02/01/2007 | US20070026535 Metal chelator that can be linked to a probe moiety via a hydrazone linkage, hydrazone linkage is readily formed in aqueous solution and is stable without further chemical transformation, making it particularly suitable for use with proteins, nucleic acids, and the like |
| 02/01/2007 | US20070026528 Crystallization of protein solution in micro-chambers; Sreening protein crystal propagation; provide microarray, expose to protein crystal sample to support, monitor protein crystal growth or protein precipitation in wells |
| 02/01/2007 | US20070026527 Means for detecting pathological transformation of the app protein and their uses |
| 02/01/2007 | US20070026526 Using decomposing resin materials as tool in detecting hazardous substances and lead |
| 02/01/2007 | US20070026525 Methods of chromogen separation-based image analysis |
| 02/01/2007 | US20070026524 Reliably measure the acidity of oil samples available in small amounts; monitoring of the evolution of the acid distribution of a site polluted by hydrocarbons |
| 02/01/2007 | US20070026522 Method of judging suitability of raw barley for feedstock for malt production according to staining technique |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026500 Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026478 Hemiasterlin affinity probes and their uses |
| 02/01/2007 | US20070026477 Whole cell assay involving cathepsin s |
| 02/01/2007 | US20070026475 Kinase and phosphatase activity measurement using fluorescent polarization |
| 02/01/2007 | US20070026474 provides highly purified polypeptides and antibodies for use in accurate assays |
| 02/01/2007 | US20070026473 Antibody profiles characteristic of tuberculosis state |
| 02/01/2007 | US20070026472 Sterilization wrap with additional strength sheet |
| 02/01/2007 | US20070026471 Glypican-1 in human breast cancer |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026469 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026468 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
| 02/01/2007 | US20070026467 Lupus anticoagulant testing |
| 02/01/2007 | US20070026466 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 02/01/2007 | US20070026465 Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026463 Compositions and methods of mutant Nogo-66 domain proteins |
| 02/01/2007 | US20070026460 extractants employed are ionic liquids of the general formula K+A-; kits |
| 02/01/2007 | US20070026459 Partitioning of label substance between solid and liquid phase; determination; immunoassay; incubation sample; binding; immobilization; using fluorescence or chemiluminescence labels; separation |
| 02/01/2007 | US20070026458 Assessing insulin resistance using biomarkers |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026456 Method of biomolecule analysis and method of identifying biomolecule therewith |
| 02/01/2007 | US20070026455 Method of producing hybridoma and utilization thereof |
| 02/01/2007 | US20070026454 Human secreted proteins |
| 02/01/2007 | US20070026453 Kits for classification of patients who are unlikely to be cured by conventional therapy and in whom investigational approaches would be justified in an effort to improve their outcome |
| 02/01/2007 | US20070026452 Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 02/01/2007 | US20070026451 Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026447 Nucleotides |
| 02/01/2007 | US20070026445 Novel steroid-activated nuclear receptors and uses therefor |
| 02/01/2007 | US20070026441 Methods for reducing viral load in HIV-1-infected patients |
| 02/01/2007 | US20070026440 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry |
| 02/01/2007 | US20070026434 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
| 02/01/2007 | US20070026433 Epitope testing using soluble HLA |
| 02/01/2007 | US20070026431 Modulation of MAPK-mediated phosphorylation and/or FBXW8-mediated ubiquitinylation of cyclin D1 in modulation of cellular proliferation |
| 02/01/2007 | US20070026429 Binary probe and clamp composition and methods for target hybridization detection |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026419 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |